Skip to Content Skip to Navigation

Over ons Praktische zaken Waar vindt u ons M. (Mark) Siderius

University Medical Center Groningen

M. (Mark) Siderius

Promovendus

Profielfoto van M. (Mark) Siderius

Faculteit Medische Wetenschappen/UMCG

Telefoon:

06 2564 6998 (Dienst telefoon (18295 UMCG))

050 361 4006 (Kantoor)

050 361 3432 (Secretariaat Reumatologie & Klinische Immunologie)

E-mail:

m.siderius umcg.nl

Homepage ORCID Research Portal

Publicaties

Exploring the effects of biological DMARDs on bone metabolism and outcome in axial spondyloarthritis

Siderius, M., 2025, [Groningen]: University of Groningen. 198 blz.

Onderzoeksoutput

Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis

Siderius, M., Wink, F., Kieskamp, S., Maas, F., Bos, R., Kroese, F. G. M., Spoorenberg, A. & Arends, S., okt.-2024, In: SEMINARS IN ARTHRITIS AND RHEUMATISM. 68, 8 blz., 152523.

Onderzoeksoutput › › peer review

Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients

Kampman, A., Wink, F., Paap, D., Carbo, M., Siderius, M., Kieskamp, S., Maas, F., Spoorenberg, A. & Arends, S., mrt.-2024, In: Arthritis Care & Research. 76, 3, blz. 350-358 9 blz.

Onderzoeksoutput › › peer review

After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis

Siderius, M., Spoorenberg, A., Kroese, F. G. M., van der Veer, E. & Arends, S., 24-mrt.-2023, In: PLoS ONE. 18, 3, 14 blz., e0283579.

Onderzoeksoutput › › peer review

Serum levels of bone turnover markers including calculation of Z-scores: Data from a Dutch healthy reference cohort

Siderius, M., Arends, S., Kobold, A. M., Wagenmakers, L., Koerts, K., Spoorenberg, A. & van der Veer, E., dec.-2023, In: Bone reports. 19, 8 blz., 101724.

Onderzoeksoutput › › peer review

Stable bone turnover markers corrected for age and gender during the first year of secukinumab treatment in radiographic axial spondyloarthritis

Siderius, M., Arends, S., Wink, F., Kroese, F. G. M. & Spoorenberg, A., sep.-2023, In: Clinical and Experimental Rheumatology. 41, 9, blz. 1942-1943 2 blz.

Onderzoeksoutput › › peer review

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice

Siderius, M., Kieskamp, S. C., Wink, F., Kroese, F. G. M., Arends, S. & Spoorenberg, A., 14-dec.-2023, In: Biologics: Targets and Therapy. 17, blz. 161-166 6 blz.

Onderzoeksoutput › › peer review

Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy

Rademacher, J., Siderius, M., Gellert, L., Wink, F. R., Verba, M., Maas, F., Tietz, L. M., Poddubnyy, D., Spoorenberg, A. & Arends, S., apr.-2022, In: SEMINARS IN ARTHRITIS AND RHEUMATISM. 53, 10 blz., 151974.

Onderzoeksoutput › › peer review

Patient characteristics and clinical assessments associated with progression from non-radiographic axial spondyloarthritis to ankylosing spondylitis

Kieskamp, S., Wilbrink, R., Siderius, M., Wink, F., Bos, R., Bootsma, H., Arends, S. & Spoorenberg, A., jun.-2022, In: Annals of the Rheumatic Diseases. 81, blz. 814-814 1 blz.

Onderzoeksoutput ›

Spinal radiographic progression and its association with progression to ankylosing spondylitis in patients with non-radiographic axial spondyloarthritis

Kieskamp, S., Siderius, M., Wilbrink, R., Maas, F., Wink, F., Bos, R., Bootsma, H., Arends, S. & Spoorenberg, A., jun.-2022, In: Annals of the Rheumatic Diseases. 81, blz. 813-813 1 blz.

Onderzoeksoutput ›

Alle (15) publicaties

Bekijk volledig onderzoeksprofiel

Volg de RUGfacebook linkedin rss instagram youtube